We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-0.05%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$17.5B
AUM Growth
-$4.53B
Cap. Flow
-$3.73B
Cap. Flow %
-21.26%
Top 10 Hldgs %
49.23%
Holding
203
New
48
Increased
29
Reduced
30
Closed
31

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$292M
2
KKR icon
KKR & Co
KKR
+$280M
3
ROIV icon
Roivant Sciences
ROIV
+$248M
4
MA icon
Mastercard
MA
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$133M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$650M
2
CYBR
CyberArk
CYBR
+$470M
3
CRM icon
Salesforce
CRM
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

Rank Sector Weight
1 Healthcare 50.56%
2 Financials 12.21%
3 Technology 11.18%
4 Consumer Discretionary 5.09%
5 Industrials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$1.5B 8.53%
2,300,000
-700,000
-23% -$476M
RVMD icon
2
Revolution Medicines
RVMD
$38.1B
$1.32B 7.54%
13,604,796
-978,000
-7% -$98.8M
AMZN icon
3
Amazon
AMZN
$2.69T
$879M 5.01%
4,218,394
-281,500
-6% -$62M
MSFT icon
4
Microsoft
MSFT
$2.98T
$868M 4.95%
2,344,779
+130,700
+6% +$54.7M
AON icon
5
Aon
AON
$78.7B
$811M 4.62%
2,512,638
-152,600
-6% -$50.7M
BBIO icon
6
BridgeBio Pharma
BBIO
$15.7B
$695M 3.96%
9,365,463
+367,000
+4% +$26.6M
PPA icon
7
PUT
Invesco Aerospace & Defense ETF
PPA
$7.95B
$691M 3.94%
+3,600,000
New +$629M
PTGX icon
8
Protagonist Therapeutics
PTGX
$8.49B
$669M 3.81%
6,348,906
+204,900
+3% +$18.1M
NTRA icon
9
Natera
NTRA
$38.6B
$641M 3.66%
3,207,366
-707,000
-18% -$152M
EXEL icon
10
Exelixis
EXEL
$14B
$562M 3.21%
13,111,010
-2,598,490
-17% -$112M
AVGO icon
11
Broadcom
AVGO
$1.78T
$551M 3.14%
1,779,500
+887,100
+99% +$292M
UNH icon
12
UnitedHealth
UNH
$384B
$493M 2.81%
1,821,706
+222,800
+14% +$66.4M
SNPS icon
13
Synopsys
SNPS
$79.9B
$481M 2.74%
1,213,300
+214,100
+21% +$96.8M
BSX icon
14
Boston Scientific
BSX
$66.3B
$469M 2.67%
7,470,684
+31,120
+0.4% +$2.49M
TMO icon
15
Thermo Fisher Scientific
TMO
$202B
$433M 2.47%
881,485
+245,800
+39% +$133M
KKR icon
16
KKR & Co
KKR
$92.3B
$432M 2.46%
4,671,800
+2,654,100
+132% +$280M
LNTH icon
17
Lantheus
LNTH
$6.84B
$424M 2.41%
5,583,479
+156,000
+3% +$11.2M
WAB icon
18
Wabtec
WAB
$44.8B
$402M 2.29%
1,609,403
-866,600
-35% -$210M
SCHW
19
Charles Schwab
SCHW
$179B
$372M 2.12%
3,955,657
+616,000
+18% +$60.4M
LQDA icon
20
Liquidia Corp
LQDA
$6.69B
$327M 1.86%
8,656,038
– –
CRNX icon
21
Crinetics Pharmaceuticals
CRNX
$8.88B
$303M 1.73%
8,338,098
+1,405,000
+20% +$62.8M
GOOG icon
22
Alphabet (Google) Class C
GOOG
$4.32T
$286M 1.63%
996,231
+209,191
+27% +$65.7M
ROIV icon
23
Roivant Sciences
ROIV
$24.4B
$268M 1.53%
9,675,000
+9,638,000
+26,049% +$248M
V icon
24
Visa
V
$694B
$254M 1.45%
840,710
+144,800
+21% +$46.6M
ARMK icon
25
Aramark
ARMK
$15B
$249M 1.42%
6,135,431
-3,221,615
-34% -$128M
1
2 3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return

Farallon Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Farallon Capital Management held 203 positions worth $17.5B, down 21% from $22.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Farallon Capital Management withdrew a net $3.73B in Q1 2026, closing 31 positions and reducing 30 holdings. Its most notable exit was Exact Sciences, an estimated $650M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 43% a quarter earlier, followed by Financials and Technology.

Against the trend, Farallon Capital Management opened a new position in Dianthus Therapeutics worth $70.2M.

  • Farallon Capital Management's largest Q1 2026 buy was Dianthus Therapeutics: 836,000 shares worth $70.2M.
  • Farallon Capital Management added most to Broadcom in Q1 2026, an estimated $292M increase.
  • Farallon Capital Management's biggest Q1 2026 reduction was Wabtec, cutting an estimated $210M.
  • Farallon Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $650M.
  • Farallon Capital Management's ten largest holdings make up 49% of its $17.5B portfolio in Q1 2026.
  • Farallon Capital Management opened 48 new positions and closed 31 in Q1 2026.
  • Farallon Capital Management's portfolio value fell 21% quarter-over-quarter to $17.5B.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.